MedDataX Logo

Cognitive and Psychosocial Benefits of MISC Training for Ugandan Children

NCT00889395 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2009-05-15

No results posted yet for this study

Summary

The Mediational Interventions for Sensitizing Caregivers (MISC) model developed by Professor Pnina Klein is to enhance the cognitive and social development of children throughout the developing world . Although MISC has proven effective in a longitudinal study in two poorer communities of Addis Ababa, Ethiopia , it has not been used with HIV households or in the Ugandan context where there is desperate need for enhanced caregiving in HIV-affected families. We propose to work with community leaders, healthcare workers, and parents/caregivers in adapting MISC to the Ugandan cultural and social context in Kayunga. For intervention families, MISC training will be added to an ongoing home health care visit (HHCV) program already in place for HIV children in Kayunga district. We will then evaluate whether MISC parent/caregiver training improves cognitive and psychosocial development in their children, and whether clinical stability of the HIV child is an important modifier for MISC training benefit.

Conditions

  • HIV
  • HIV Infections

Interventions

BEHAVIORAL

MISC training for primary caregivers

Caregivers of children in the intervention arm will undergo a year long training in MISC

Sponsors & Collaborators

  • Michigan State University

    collaborator OTHER

  • Makerere University

    lead OTHER

Principal Investigators

  • Noeline Nakasujja, MD · Makerere University

  • Michael Boivin, PhD · Michigan State University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Months
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2011-04-30
Completion
2011-06-30

Countries

  • Uganda

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00889395 on ClinicalTrials.gov